ArticleBMC public health2021

Acceptability, feasibility, and likelihood of stakeholders implementing the novel BPaL regimen to treat extensively drug-resistant tuberculosis patients.

S E J van de Berg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.